UELifeSciences is a women's health company dedicated to making early detection of cancer accessible through innovation. With a team of dedicated professionals including engineers, clinicians, and health workers spread across the USA, India, and Malaysia, UELifeSciences is committed to impacting women globally. They are the creators of award-winning products such as iBreastExam and cervAIcal.

iBreastExam is a breakthrough, patent-pending, radiation-free, ultra-portable wireless device that can be used by lay health workers to quickly and easily identify and document small, non-palpable lumps at the point of care. This FDA cleared device is currently in commercialization. cervAIcal is an AI-enabled mobile colposcope designed for cervical cancer screening.

It is a high-quality, wireless universal cervical examination assistant that can be taken to wherever the patients are. Ongoing pilots are being conducted for this innovative product. In addition to their B2B offerings, UELifeSciences is also developing Selfi, the world's first at-home breast health monitoring device, app, and platform.

This groundbreaking technology is expected to be commercially launched in 2022. With a proven track record, UELifeSciences has enabled over 2 million breast exams and detected over 500 cancers. They have successfully entered 10 markets, received $1.

7 million in grant awards, and raised $8. 5 million in capital. For more information or to get in touch, visit their website or reach out via phone or email.

Together with UELifeSciences, we can make early detection a reality and positively impact the lives of women worldwide